Zivo Bioscience Inc (ZIVO)

Zivo Bioscience, Inc. is a common stock listing on OTC Markets. The company and its subsidiaries focus on licensing and selling natural bioactive ingredients derived from proprietary algae cultures for use by animal, human, dietary supplement, and medical food manufacturers. Its activities span biotech and agtech applications, supported by an intellectual property portfolio that includes proprietary algal and bacterial strains, biologically active compounds, cultivation methods, production techniques, and patented or patent-pending inventions. Zivo Bioscience’s product and ingredient work includes areas such as poultry gut health, avian influenza, bovine mastitis, canine joint health, human immune modulation, functional food ingredients, algal biomass for human food, and biomass associated with skin health and anti-aging. The company was previously known as Health Enhancement Products, Inc. and adopted its current name in October 2014. It is headquartered in Troy, Michigan.


Jump directly to the stock analysis sections supported by the latest available data.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
Ticker Fair Value Fair Value Upside/Downside Fair Value Rating Analyst Price Target Analyst Target Upside/Downside Overall Financial Health Dividend Yield Price-to-Sales Ratio Market Cap Enterprise Value Total Debt / Total Capital Free Float / Shares Outstanding Altman Z-Score Free Cash Flow / Net Income
OTC-ZIVO
$3.98
12.0% Upside
Fair
Not available
Not available
Weak
0.0%
63.6x
14.738 M
14.048 M
5.8%
37.9%
-414.6
36.3%
Valuation • Fair Value

Zivo Bioscience Inc (OTC-ZIVO) Fair Value by Valuation Model

Review the available estimates for Zivo Bioscience Inc (OTC-ZIVO), including Comps Fair Value.

Primary Valuation Read

Fair Value

$3.98

Estimated upside of 12.0% versus the current market price.

Fair Value Confidence

Low

Confidence level for the primary fair value estimate.

Comps Fair Value

$3.98

Comparable-company valuation reference.

Analyst Price Target

Not available

Data is currently unavailable.

How to read these valuation models

Use the 3 available valuation references for Zivo Bioscience Inc (OTC-ZIVO) as analytical inputs, not a standalone conclusion. Valuation methods can differ because they rely on different assumptions, time horizons and financial inputs; compare the estimates with the current price and the company’s financial quality.

Profitability • Growth

Profitability & Growth for Zivo Bioscience Inc (OTC-ZIVO)

Review the profitability and growth indicators currently supported by the latest data.

Revenue

209.025 K

Current operating scale indicator.

Revenue Forecast

213 K

Forward revenue estimate.

EBITDA

-8.393 M

Current operating profitability reference.

EBITDA Forecast

-7.889 M

Forward operating profitability estimate.

How to read profitability and growth

This section helps investors review Zivo Bioscience Inc (OTC-ZIVO) from an operating perspective by combining current scale, forward revenue expectations and EBITDA-related profitability measures.

Quality • Risk

Quality & Financial Risk for Zivo Bioscience Inc (OTC-ZIVO)

Review the financial quality and risk indicators currently supported by the latest data.

Financial Health

Weak

Financial pressure deserves closer review.

Piotroski Score

3

Weak quality score that deserves closer review.

Altman Z-Score

-414.6

Lower score that deserves closer risk review.

FCF / Net Income

36.3%

Cash conversion quality indicator.

How to read quality and risk

This section combines quality, balance-sheet and accounting-risk indicators for Zivo Bioscience Inc (OTC-ZIVO). Read the metrics together: no single score is a complete investment conclusion, but the combined view can highlight financial strength, earnings quality and areas that may deserve closer review.

Events • Dividends

Dividend Profile for Zivo Bioscience Inc (OTC-ZIVO)

Review the dividend metrics currently supported by the latest data.

Dividend Yield

0.0%

No current dividend yield is indicated.

How to read events and dividends

The latest data indicates no current dividend yield for Zivo Bioscience Inc (OTC-ZIVO). No upcoming dividend amount or event date is currently available.

Stock Forecast • Technical Outlook

Zivo Bioscience Inc (OTC-ZIVO) Stock Forecast & Technical Outlook

Review Zivo Bioscience Inc (OTC-ZIVO) across multiple technical time frames, alongside analyst recommendation data, to form a faster read on market positioning and near-term sentiment.

Technical Signals by Time Frame

Switch between time frames to review the current technical signal for the stock.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 15-minute • intraday
Buy

The 15-minute technical read for Zivo Bioscience Inc (OTC-ZIVO) is currently Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 1-hour • short-term
Neutral

The 1-hour technical read for Zivo Bioscience Inc (OTC-ZIVO) is currently Neutral. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: daily • daily
Strong Sell

The daily technical read for Zivo Bioscience Inc (OTC-ZIVO) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: weekly • weekly
Strong Sell

The weekly technical read for Zivo Bioscience Inc (OTC-ZIVO) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: monthly • monthly
Strong Sell

The monthly technical read for Zivo Bioscience Inc (OTC-ZIVO) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Analyst Consensus for Zivo Bioscience Inc (OTC-ZIVO)

A consolidated view of buy, hold and sell recommendations based on the currently available analyst data.

Strong Sell Sell Neutral Buy Strong Buy
Consolidated analyst recommendation mix
Hold

Based on the available recommendation mix, Zivo Bioscience Inc (OTC-ZIVO) has a Hold consensus, with 0 buy, 1 hold and 0 sell recommendations in the current data set.

Buy 0
Hold 1
Sell 0
FAQ Fast Investor Answers

Zivo Bioscience Inc (OTC-ZIVO) Stock FAQ

Data-supported answers about Zivo Bioscience Inc (OTC-ZIVO), including explicit coverage status where a reliable valuation estimate is not currently available.

Fair Value
$3.98
Estimated upside 12.0%
Valuation Rating
Undervalued
Estimated upside of 12.0%
Financial Health
Weak
Current financial-health read

The current fair value estimate for Zivo Bioscience Inc (OTC-ZIVO) is $3.98. This implies an estimated upside of 12.0% versus the current market price.

Based on the current fair value estimate, the stock appears undervalued, with estimated upside of 12.0% versus the current market price.

The current financial health read for Zivo Bioscience Inc (OTC-ZIVO) is Weak. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

The latest available data indicates no current dividend yield for Zivo Bioscience Inc (OTC-ZIVO).

The current market capitalization listed for Zivo Bioscience Inc is 14.738 M.

The current enterprise value listed for Zivo Bioscience Inc is 14.048 M. Enterprise value can provide a broader valuation view than market capitalization alone because it also considers net debt.

The ticker symbol for Zivo Bioscience Inc is OTC-ZIVO, and the stock is listed on OTC Markets.

Zivo Bioscience Inc (OTC-ZIVO) is listed on OTC Markets.

The current debt-to-total-capital ratio listed for Zivo Bioscience Inc is 5.8%, which helps investors evaluate the company’s financing structure and leverage profile.

The free float listed for Zivo Bioscience Inc is 37.9%. Free float helps investors understand how much of the share base is available for public trading.